PQQ Disodium
Also known as: PQQ disodium, PQQ, methoxatin, Pyrroloquinoline quinone disodium salt
Overview
Pyrroloquinoline quinone disodium salt (PQQ disodium) is a naturally occurring redox cofactor found in soil, plants, and certain foods like fermented soybeans and kiwi. The disodium salt form is commonly used in dietary supplements due to its enhanced stability and bioavailability. PQQ is primarily recognized for its potent antioxidant properties, its ability to stimulate mitochondrial biogenesis, and its potential to offer neuroprotective, cardioprotective, and metabolic health benefits. While extensive research has been conducted in vitro and in animal models, human clinical studies are emerging but still limited. The current evidence base is considered moderate, with several well-controlled animal studies and mechanistic human trials providing promising insights, though comprehensive systematic reviews and meta-analyses in humans are scarce. PQQ's role as a mitochondrial cofactor positions it as a key player in cellular energy metabolism and overall cellular health.
Benefits
PQQ disodium offers several evidence-based benefits, primarily stemming from its role in mitochondrial function and antioxidant activity. Its most significant effect is the stimulation of mitochondrial biogenesis, which improves cellular energy metabolism and overall cellular health, as supported by studies like Jonscher et al. (2021). In animal models, PQQ has demonstrated strong cardioprotective effects, reducing oxidative stress, infarct size, and improving heart function following ischemic injury (Yan et al., 2024). Furthermore, PQQ shows promise for metabolic health, with animal studies indicating its ability to reduce visceral and hepatic fat accumulation, improve lipid profiles, and attenuate inflammation in models of obesity and metabolic syndrome (Mohamad Ishak et al., 2023). It has also been shown to lower total cholesterol, triglycerides, and LDL in high-fat diet mice (Wang et al., 2023). Secondary benefits include potential neuroprotection and cognitive improvements, though these require more robust human randomized controlled trial (RCT) data. PQQ has also been observed to improve male reproductive function by protecting against Leydig cell pyroptosis in obese mice (Wang et al., 2023). While human data are limited, the strong and statistically significant improvements observed in animal studies across mitochondrial markers, lipid metabolism, and cardiac function suggest promising applications for human metabolic and cardiovascular health.
How it works
PQQ disodium functions primarily as a redox cofactor and a powerful antioxidant. It effectively scavenges reactive oxygen species (ROS), thereby protecting mitochondrial membranes from oxidative damage. A key mechanism involves its ability to promote mitochondrial biogenesis by activating crucial signaling pathways such as PGC-1α and NRF1. This leads to the growth of new mitochondria and improved cellular energy production. PQQ also influences lipid metabolism by affecting cholesterol uptake and suppressing inflammatory pyroptosis pathways, specifically the PCSK9-NLRP3 pathway in Leydig cells. Furthermore, PQQ can form imidazole derivatives with amino acids, indicating complex biochemical interactions within the body. The disodium salt form ensures adequate oral bioavailability, allowing absorbed PQQ to reach various tissues and exert its systemic effects.
Side effects
PQQ disodium salt is generally considered safe, having received a Generally Recognized As Safe (GRAS) designation by the FDA in 2015. Toxicology studies have shown no evidence of mutagenicity or genotoxicity in standard assays, including bacterial reverse mutation, sperm malformation, and micronucleus tests. Acute oral toxicity studies in rats indicate a low toxicity profile, with LD50 values ranging from 3,690 to 5,010 mg/kg. A 13-week repeated dose study in rats found no adverse effects on body weight, food consumption, hematology, serum biochemistry, or histopathology at tested doses. To date, no significant side effects have been reported in human trials, although the available human data are limited. There are no known major drug interactions, but caution is advised when combining PQQ with other antioxidant or mitochondrial-targeted therapies due to potential additive effects. Contraindications and safety data for specific populations, such as pregnant women or children, are insufficient, and therefore, use in these groups should be approached with caution.
Dosage
Human clinical dosing for PQQ disodium is not yet fully standardized due to limited human trials. However, common supplement doses typically range from 10 to 20 mg per day of PQQ disodium. These dosages are largely extrapolated from animal studies, where equivalent doses often fall within 10–20 mg/kg body weight. There is currently no established maximum safe dose for humans, but animal studies indicate a No Observed Adverse Effect Level (NOAEL) of approximately 400 mg/kg/day. For optimal absorption, oral administration with meals is generally recommended, as the disodium salt form is known to enhance bioavailability. While no specific cofactors are strictly required for PQQ's efficacy, co-supplementation with other mitochondrial health supporters like CoQ10 or B vitamins may provide additional benefits.
FAQs
Is PQQ safe for long-term use?
Current animal studies support the safety of PQQ, even at high doses. However, more long-term human studies are needed to definitively confirm its safety profile over extended periods in humans.
How quickly do benefits appear?
Animal studies have shown improvements in mitochondrial function and metabolic parameters within weeks of PQQ supplementation. The timeline for observable benefits in humans may vary and requires further research.
Can PQQ be combined with other antioxidants?
PQQ is likely safe to combine with other antioxidants, given its favorable safety profile. However, clinical data on such combinations are limited, and caution is advised.
Does PQQ improve cognitive function?
Preliminary evidence suggests potential cognitive benefits from PQQ, but more rigorous and extensive human clinical trials are necessary to confirm these effects and establish optimal dosages for cognitive improvement.
Research Sources
- https://www.fda.gov/files/food/published/GRAS-Notice-000590--Pyrroloquinoline-quinone.pdf – This FDA GRAS Notice details the safety assessment of PQQ disodium, concluding it is Generally Recognized As Safe. It cites toxicology studies in rats and mice, demonstrating no mutagenicity, genotoxicity, or adverse effects at high doses, supporting its safety for human consumption.
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11541945/ – This animal study investigated PQQ's cardioprotective effects. It found that PQQ significantly reduced oxidative stress and infarct size, and improved heart function in rat models following ischemic injury, highlighting its potential as a therapeutic agent for cardiac health.
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8533503/ – This comprehensive review and animal study compilation discusses PQQ's role in promoting mitochondrial biogenesis and its safety profile. It consolidates preclinical evidence showing PQQ's ability to enhance mitochondrial growth and function, and confirms its safety at high doses in various animal models.
- https://www.nature.com/articles/s41419-023-06162-8 – This animal and in vitro study explored PQQ's impact on metabolic health and male reproductive function. It demonstrated that PQQ improved lipid metabolism, enhanced testosterone synthesis, and reduced Leydig cell pyroptosis in obese mice, suggesting benefits for metabolic syndrome and reproductive health.
- https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2023.1200025/full – This review synthesizes findings from animal and cell studies regarding PQQ's effects on fat accumulation and metabolic parameters. It concludes that PQQ effectively reduces fat accumulation and improves various metabolic markers, providing strong preclinical evidence for its role in combating metabolic disorders.